1009376-74-2

Basic information

• Product Name: 3-Piperidinecarboxylic acid, 6-Methyl-, Methyl ester, hydrochloride
• Synonyms: 3-Piperidinecarboxylic acid, 6-Methyl-, Methyl ester, hydrochloride;METHYL 6-METHYLPIPERIDINE-3-CARBOXYLATE HCL;Methyl 6-Methylpiperidine-3-carboxylate Hydrochloride
• CAS NO: 1009376-74-2
• Molecular Formula: C₈H₁₅NO₂*ClH
• Molecular Weight: 193.67114
• Mol File: 1009376-74-2.mol
• Article Data: 2

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 3-Piperidinecarboxylic acid, 6-Methyl-, Methyl ester, hydrochloride(CAS DataBase Reference)
• NIST Chemistry Reference: 3-Piperidinecarboxylic acid, 6-Methyl-, Methyl ester, hydrochloride(1009376-74-2)
• EPA Substance Registry System: 3-Piperidinecarboxylic acid, 6-Methyl-, Methyl ester, hydrochloride(1009376-74-2)

Safety Data

• Hazardous Substances Data: 1009376-74-2(Hazardous Substances Data)

Upstream product

• 5470-70-2 Methyl 6-methylnicotinate 

Downstream Products

• 1227917-62-5 (3R,6S)-3-methyl 1-(phenylmethyl) 6-methyl-1,3-piperidinedicarboxylate 
• 1227917-61-4 (3R,6S)-6-methyl-1-{[(phenylmethyl)oxy]carbonyl}-3-piperidinecarboxylic acid 
• 1009376-48-0 (3R,6S)-Methyl 1-[1-(4-Chlorophenyl)cyclobutanecarbonyl]-6-methylpiperidine-3-carboxylate 
• 908245-08-9 C₁₆H₂₁NO₄ 

Relevant articles and documents

4-(5-Membered fused pyridinyl)benzamides as BTK-inhibitors

The present invention provides 6-5 membered fused pyridine ring compounds according to Formula I or pharmaceutically acceptable salts thereof. or a pharmaceutically acceptable salt thereof or to pharmaceutical compositions comprising these compounds and to their use in therapy. In particular, the present invention relates to the use of 6-5 membered fused pyridine ring compounds in the treatment of Bruton's Tyrosine Kinase (Btk) mediated disorders.